Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Neurosurgery

Surgical Treatment: Restoring Blood Flow to the Brain

At a Glance

Moyamoya surgery creates new routes for blood to reach the brain. Direct bypass can improve flow immediately, while indirect bypass grows new vessels over months; surgery lowers but does not eliminate stroke risk, so ongoing follow-up is essential.

Because Moyamoya is a progressive condition, the narrowing of the arteries typically continues over time. While medications can help manage symptoms, surgery is considered the primary disease-directed treatment for many symptomatic or hemodynamically impaired patients because it physically increases the blood supply to the brain and lowers the long-term risk of stroke [1][2]. However, management is individualized, and surgery reduces rather than eliminates stroke risk.

The Role of Medical Management

Before or alongside surgery, your doctor will likely prescribe “medical management.” It is important to understand that these treatments do not fix the narrowed arteries, but they help protect the brain from the consequences of low blood flow.

  • Antiplatelet Therapy: Low-dose aspirin is often considered for selected patients to reduce ischemic risk [3][4]. It works by making the blood “less sticky,” which may prevent tiny clots from forming in the narrowed vessels [5]. However, Moyamoya ischemia is often a problem of low flow rather than just clots, and aspirin use must be carefully weighed against your bleeding risk. It is not a substitute for revascularization or a guarantee against stroke.
  • Hydration: Avoiding dehydration supports cerebral perfusion [6]. However, hydration goals are set by your clinician.
  • Symptom Support: Other medications may be used to manage specific symptoms like migraines or seizures, individualized based on your needs [7][8].

Surgical Options: Building New Pathways

The goal of surgery, known as revascularization, is to provide a detour for blood to reach the brain. There are three main ways surgeons achieve this, chosen according to vessel caliber, age, anatomy, symptoms, and local expertise:

1. Direct Bypass

The most common direct procedure is the STA-MCA bypass (Superficial Temporal Artery to Middle Cerebral Artery). The surgeon takes a healthy artery from the scalp and stitches it directly onto an artery on the surface of the brain [1][9].

  • Benefit: It provides immediate blood flow to the brain [10].
  • Challenge: It is technically difficult. It is more common in adults, but can be performed in selected children whose vessels are large enough [1].

2. Indirect Bypass

In an indirect bypass, such as EDAS or EMS, the surgeon places blood-rich tissue (like a scalp artery or a piece of muscle) directly onto the surface of the brain without stitching the vessels together [1][11].

  • Benefit: Over several months, the brain naturally grows new tiny vessels into that tissue, creating a biological bypass [10][12].
  • Challenge: It takes time. Indirect collateral growth is variable and you may not see the full benefit for 3 to 12 months after the operation, leaving an interim period where close protection and follow-up are still needed [10]. This is often the preferred choice for young children [9].

3. Combined Bypass

This procedure combines both techniques, providing a direct bypass for immediate flow while laying down tissue for an indirect bypass to grow more vessels over time [1][13]. Many centers use this combined approach, although evidence does not establish it as universally superior to indirect surgery for every patient [9][14].

Understanding Potential Complications

While surgery substantially reduces future ischemic risk in appropriate patients, the process of altering how blood flows to the brain carries specific risks that your team will monitor closely.

  • Hyperperfusion Syndrome: This occurs when a brain adapted to low blood flow receives a sudden surge of flow after a direct bypass [15][16]. This sudden increase can overwhelm the brain’s ability to regulate pressure, leading to intense headaches, temporary confusion, seizures, or, in rare cases, bleeding in the brain [15][17]. Doctors manage this by very strictly controlling blood pressure [18][19]. Do not attempt to adjust your own blood pressure medications.
  • Watershed-Shift Phenomenon: A temporary “tug-of-war” for blood flow. When a new bypass is created, the new blood flow can sometimes divert blood away from adjacent areas of the brain that were already struggling [20]. specialized scans help doctors monitor this [18][21].
  • Other Complications: Beyond hyperperfusion and watershed shift, surgery carries risks of perioperative ischemic stroke, intracranial bleeding, bypass occlusion (failure), incomplete indirect vessel growth, seizures, infection, wound problems, anesthetic complications, and the possibility of further surgery.

Recovery and Long-Term Outlook

Most patients stay in the hospital for a few days after surgery for close monitoring [6][4]. Once discharged, any new weakness, speech trouble, confusion, severe headache, reduced consciousness, or seizure requires immediate emergency assessment. While the surgery significantly reduces the risk of future strokes, it is not a cure that eliminates the need for follow-ups [22]. You will need ongoing surveillance to ensure the bypass remains open and check if the disease is progressing in other areas [22][23].

Common questions in this guide

Why is surgery used to treat Moyamoya disease?
Surgery creates new routes for blood to reach the brain when Moyamoya has reduced blood flow. It is the main disease-directed treatment for many people with symptoms or evidence of inadequate brain circulation, but it lowers rather than eliminates future stroke risk.
What is the difference between direct and indirect Moyamoya bypass surgery?
A direct bypass connects a scalp artery directly to an artery on the brain’s surface and can improve blood flow immediately. An indirect bypass places blood-rich tissue near the brain so new vessels can grow over time, which makes it slower and often useful in young children.
How long does an indirect Moyamoya bypass take to work?
New blood vessels after an indirect bypass may take about 3 to 12 months to develop, and the timing varies from person to person. Follow-up scans help the medical team determine how much new circulation has formed during this waiting period.
What complications can happen after Moyamoya surgery?
Possible complications include too much blood flow to the brain, a temporary shift of blood away from nearby areas, stroke, bleeding, blockage of the bypass, incomplete new-vessel growth, seizures, infection, and wound or anesthesia problems. The surgical team uses close monitoring and careful blood-pressure management to reduce and detect these risks.
Which symptoms require emergency care after Moyamoya surgery?
New weakness, trouble speaking, confusion, a severe headache, reduced alertness, or a seizure after discharge requires immediate emergency assessment. Do not change blood-pressure or other medicines on your own while waiting for advice.
Will I need follow-up after Moyamoya bypass surgery?
Yes. Surgery does not cure Moyamoya or guarantee that a bypass will remain open, so ongoing visits and brain or blood-vessel imaging are needed to check circulation and look for disease progression in other areas.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Moyamoya disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my (or my child's) age and the size of our blood vessels, do you recommend a direct, indirect, or combined bypass?
  2. 2.How many of these specific procedures does this surgical team perform each year, and what are your complication rates?
  3. 3.What is your protocol for monitoring and managing 'hyperperfusion' or 'watershed shift' in the first few days after surgery?
  4. 4.What is the exact, written plan for my aspirin and blood pressure medications before and after surgery?
  5. 5.How long after an indirect bypass should we expect to see new blood vessel growth on a follow-up angiogram?

References

References (23)
  1. 1

    Superficial temporal artery-middle cerebral artery anastomosis patency correlates with cerebrovascular reserve in adult moyamoya syndrome patients.

    Aboukais R, Verbraeken B, Leclerc X, et al.

    Neuro-Chirurgie 2019; (65(4)):146-151 doi:10.1016/j.neuchi.2019.05.001.

    PMID: 31185229
  2. 2

    Moyamoya Across the Lifespan: Current Neurologic Care and Future Directions.

    Sun LR, Vossough A, Kossorotoff M, et al.

    Neurology 2025; (104(7)):e213484 doi:10.1212/WNL.0000000000213484.

    PMID: 40036714
  3. 3

    Trends of Antiplatelet Therapy for the Management of Moyamoya Disease in Japan: Results of a Nationwide Survey.

    Oki K, Katsumata M, Izawa Y, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2018; (27(12)):3605-3612 doi:10.1016/j.jstrokecerebrovasdis.2018.08.030.

    PMID: 30220629
  4. 4

    Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi Study.

    Sun LR, Jordan LC, Smith ER, et al.

    Neurocritical care 2024; (40(2)):587-602 doi:10.1007/s12028-023-01788-0.

    PMID: 37470933
  5. 5

    Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease.

    Ye F, Li J, Wang T, et al.

    Frontiers in neurology 2020; (11()):608000 doi:10.3389/fneur.2020.608000.

    PMID: 33519687
  6. 6

    Update on the anesthesia management in adult patients with moyamoya disease.

    Yang KJ, Mistry P, Ayrian E

    Current opinion in anaesthesiology 2024; (37(5)):439-445 doi:10.1097/ACO.0000000000001411.

    PMID: 39011661
  7. 7

    The Spectrum of Headaches in Moyamoya Angiopathy: From Mechanisms to Management Strategies-A Consensus Review From the NEUROVASC Working Group.

    Rifino N, Aamodt AH, Wiedmann M, et al.

    European journal of neurology 2025; (32(10)):e70316 doi:10.1111/ene.70316.

    PMID: 41039799
  8. 8

    Seizure outcome in moyamoya after indirect revascularization in pediatric patients: Retrospective study and literature review.

    Alramadan A, Ul Haq A, Basindwah S, Alshail E

    Surgical neurology international 2021; (12()):73 doi:10.25259/SNI_633_2020.

    PMID: 33767877
  9. 9

    Superficial temporal artery-to-middle cerebral artery bypass in combination with indirect revascularization in moyamoya patients ≤ 3 years of age.

    Bot GM, Burkhardt JK, Gupta N, Lawton MT

    Journal of neurosurgery. Pediatrics 2019; (23(2)):198-203.

    PMID: 30497164
  10. 10

    A novel superficial temporal artery patency concept of cerebral revascularization for patients with moyamoya disease: a multicenter study.

    Shi Z, Li X, Chen X, et al.

    Chinese neurosurgical journal 2026; (12(1)).

    PMID: 41749301
  11. 11

    Research Progress of Moyamoya Disease in Children.

    Piao J, Wu W, Yang Z, Yu J

    International journal of medical sciences 2015; (12(7)):566-75 doi:10.7150/ijms.11719.

    PMID: 26180513
  12. 12

    Superficial Temporal Artery Size Changes After Encephaloduroarteriosynangiosis for the Treatment of Moyamoya Disease.

    McNeil E, Enriquez-Marulanda A, Ramirez Velandia F, et al.

    World neurosurgery 2024; (190()):e774-e780 doi:10.1016/j.wneu.2024.07.217.

    PMID: 39127374
  13. 13

    Safety analysis of STA-MCA bypass combined with EDAS in the treatment of patients with moyamoya disease.

    Zhu C, Wang Y, Li J

    Medicine 2025; (104(12)):e41769 doi:10.1097/MD.0000000000041769.

    PMID: 40128023
  14. 14

    Direct Bypass Surgery Vs. Combined Bypass Surgery for Hemorrhagic Moyamoya Disease: A Comparison of Angiographic Outcomes.

    Zhao Y, Yu S, Lu J, et al.

    Frontiers in neurology 2018; (9()):1121 doi:10.3389/fneur.2018.01121.

    PMID: 30619072
  15. 15

    Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Patients with Moyamoya Disease: Systematic Review and Meta-Analysis.

    Yu J, Zhang J, Li J, et al.

    World neurosurgery 2020; (135()):357-366.e4 doi:10.1016/j.wneu.2019.11.065.

    PMID: 31759149
  16. 16

    Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Moyamoya Disease: Region-Symptom Mapping and Estimating a Critical Threshold.

    Kazumata K, Uchino H, Tokairin K, et al.

    World neurosurgery 2018; (114()):e388-e395 doi:10.1016/j.wneu.2018.02.190.

    PMID: 29530706
  17. 17

    Autoregulatory dysfunction in adult Moyamoya disease with cerebral hyperperfusion syndrome after bypass surgery.

    Kim JH, Hong N, Kim H, et al.

    Scientific reports 2024; (14(1)):26451 doi:10.1038/s41598-024-76559-8.

    PMID: 39488581
  18. 18

    Significance of Cerebral Blood Flow Analysis in the Acute Stage after Revascularization Surgery for Moyamoya Disease.

    Fujimura M, Tominaga T

    Neurologia medico-chirurgica 2015; (55(10)):775-81 doi:10.2176/nmc.ra.2015-0063.

    PMID: 26369873
  19. 19

    Effects of Scalp Nerve Block on Symptomatic Cerebral Hyperperfusion Syndrome After Combined Revascularization Surgery for Moyamoya Disease.

    Choi S, Park JY, Jo WY, et al.

    Journal of neurosurgical anesthesiology 2026; (38(1)):81-86 doi:10.1097/ANA.0000000000001024.

    PMID: 39800904
  20. 20

    Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.

    Tashiro R, Fujimura M, Kameyama M, et al.

    Cerebrovascular diseases (Basel, Switzerland) 2019; (47(3-4)):178-187 doi:10.1159/000500802.

    PMID: 31121577
  21. 21

    Assessment of Transient Cerebral Hemodynamic Disturbance via Whole-Brain Computed Tomography Perfusion After Extracranial-Intracranial Bypass in Ischemic Moyamoya Disease.

    Yao F, Han Q, Zhang Z, Huang Y

    World neurosurgery 2021; (146()):e112-e121 doi:10.1016/j.wneu.2020.10.046.

    PMID: 33069937
  22. 22

    Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease.

    Kuroda S, Nakayama N, Yamamoto S, et al.

    Journal of neurosurgery 2021; (134(3)):909-916 doi:10.3171/2019.12.JNS192938.

    PMID: 32168480
  23. 23

    Revascularization of Moyamoya Angiopathy in Older Adults.

    Williamson RW, Abla AA, Zabramski JM, et al.

    World neurosurgery 2017; (99()):37-40 doi:10.1016/j.wneu.2016.11.073.

    PMID: 27890765

This page is for informational purposes only and does not constitute medical advice. Your neurosurgical team should guide your choice of bypass, medication plan, blood-pressure management, and follow-up.